Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA.
Lancet. 2011 Jul 2;378(9785):31-40. doi: 10.1016/S0140-6736(11)60679-X. Epub 2011 Jun 24.
Data for trends in glycaemia and diabetes prevalence are needed to understand the effects of diet and lifestyle within populations, assess the performance of interventions, and plan health services. No consistent and comparable global analysis of trends has been done. We estimated trends and their uncertainties in mean fasting plasma glucose (FPG) and diabetes prevalence for adults aged 25 years and older in 199 countries and territories.
We obtained data from health examination surveys and epidemiological studies (370 country-years and 2·7 million participants). We converted systematically between different glycaemic metrics. For each sex, we used a Bayesian hierarchical model to estimate mean FPG and its uncertainty by age, country, and year, accounting for whether a study was nationally, subnationally, or community representative.
In 2008, global age-standardised mean FPG was 5·50 mmol/L (95% uncertainty interval 5·37-5·63) for men and 5·42 mmol/L (5·29-5·54) for women, having risen by 0·07 mmol/L and 0·09 mmol/L per decade, respectively. Age-standardised adult diabetes prevalence was 9·8% (8·6-11·2) in men and 9·2% (8·0-10·5) in women in 2008, up from 8·3% (6·5-10·4) and 7·5% (5·8-9·6) in 1980. The number of people with diabetes increased from 153 (127-182) million in 1980, to 347 (314-382) million in 2008. We recorded almost no change in mean FPG in east and southeast Asia and central and eastern Europe. Oceania had the largest rise, and the highest mean FPG (6·09 mmol/L, 5·73-6·49 for men; 6·08 mmol/L, 5·72-6·46 for women) and diabetes prevalence (15·5%, 11·6-20·1 for men; and 15·9%, 12·1-20·5 for women) in 2008. Mean FPG and diabetes prevalence in 2008 were also high in south Asia, Latin America and the Caribbean, and central Asia, north Africa, and the Middle East. Mean FPG in 2008 was lowest in sub-Saharan Africa, east and southeast Asia, and high-income Asia-Pacific. In high-income subregions, western Europe had the smallest rise, 0·07 mmol/L per decade for men and 0·03 mmol/L per decade for women; North America had the largest rise, 0·18 mmol/L per decade for men and 0·14 mmol/L per decade for women.
Glycaemia and diabetes are rising globally, driven both by population growth and ageing and by increasing age-specific prevalences. Effective preventive interventions are needed, and health systems should prepare to detect and manage diabetes and its sequelae.
Bill & Melinda Gates Foundation and WHO.
为了了解饮食和生活方式对人群的影响,评估干预措施的效果,并规划卫生服务,我们需要有关血糖和糖尿病患病率趋势的数据。尚未对全球趋势进行过一致和可比的分析。我们估计了 199 个国家和地区 25 岁及以上成年人的平均空腹血糖(FPG)和糖尿病患病率及其变化趋势和不确定性。
我们从健康检查调查和流行病学研究中获得了数据(370 个国家年和 270 万人参与)。我们系统地转换了不同的血糖指标。对于每个性别,我们使用贝叶斯层次模型来估计年龄、国家和年份的平均 FPG 及其不确定性,同时考虑到研究是全国性、次国家级还是社区代表性的。
2008 年,全球年龄标准化的平均 FPG 男性为 5.50mmol/L(95%置信区间为 5.37-5.63),女性为 5.42mmol/L(5.29-5.54),分别每十年上升 0.07mmol/L 和 0.09mmol/L。2008 年,男性糖尿病的年龄标准化患病率为 9.8%(8.6-11.2),女性为 9.2%(8.0-10.5),高于 1980 年的 8.3%(6.5-10.4)和 7.5%(5.8-9.6)。糖尿病患者人数从 1980 年的 1.53 亿(1.27-1.82)人增加到 2008 年的 3.47 亿(3.14-3.82)人。东亚和东南亚以及中东欧地区的平均 FPG 几乎没有变化。大洋洲的上升幅度最大,2008 年的平均 FPG 最高(男性为 6.09mmol/L,5.73-6.49;女性为 6.08mmol/L,5.72-6.46)和糖尿病患病率(男性为 15.5%,11.6-20.1;女性为 15.9%,12.1-20.5)。2008 年南亚、拉丁美洲和加勒比以及中亚、北非和中东地区的平均 FPG 和糖尿病患病率也很高。2008 年,撒哈拉以南非洲、东亚和东南亚以及亚太高收入地区的平均 FPG 最低。在高收入地区,西欧的增长幅度最小,男性每十年增长 0.07mmol/L,女性每十年增长 0.03mmol/L;北美增幅最大,男性每十年增长 0.18mmol/L,女性每十年增长 0.14mmol/L。
全球的血糖和糖尿病都在上升,这既归因于人口增长和老龄化,也归因于特定年龄组的患病率不断上升。需要采取有效的预防干预措施,卫生系统应准备好发现和管理糖尿病及其后果。
比尔及梅琳达·盖茨基金会和世卫组织。